Table: Peptidream - Q1 parent results
Nov 8 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Sep 30, 2017 Sep 30, 2016 Jun 30, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 171 mln 796 mln
(-78.5 pct) (+104.6 pct)
Operating loss 1.03 380 mln
(+403.9 pct)
Recurring loss 932 mln 398 mln
(+588.0 pct)
Net loss 649 mln 279 mln
(+643.7 pct)
EPS loss 5.51 yen 2.45 yen
EPS Diluted 2.15 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner